Novo Nordisk upgrades guidance for the rest of the year
The day before the publication of Novo Nordisk's Q2 report, the company has upgraded its guidance for 2021. Figures from the quarterly report show a positive surprise on the pharmaceutical company's top and bottom lines.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
Already on Wednesday afternoon, Denmark's largest pharmaceutical company, Novo Nordisk, has disclosed the figures for the second quarter of the year, while the company also upgrades its guidance for the firm's revenue and operating result.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg)
